CCL20/MIP-3α, TIMP1, IL8, PDGFR-B, CCL3/MIP-1α and CXCL9/MIG were significantly elevated in the plasma from the gastric cancer patients compared to the plasma from individuals with no visible upper gastro-intestinal pathology or those with benign lesions in stomach. This evidence concerns the gene CCL20 and gastric cancer.